Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy

• Tamara Castillo-Trivino,

  Affiliations Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America, Multiple Sclerosis Unit, Department of Neurology, Hospital Donostia, San Sebastián, Spain

  ⨯
• Ellen M. Mowry,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Alberto Gajofatto,

  Affiliation Department of Neurological and Vision Sciences, University of Verona, Verona, Italy

  ⨯
• Dorothee Chabas,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Elizabeth Crabtree-Hartman,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Bruce A. Cree,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Douglas S. Goodin,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Ari J. Green,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Darin T. Okuda,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Daniel Pelletier,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Scott S. Zamvil,

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Eric Vittinghoff,

  Affiliation Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Emmanuelle Waubant

  * E-mail: emmanuelle.waubant@ucsf.edu

  Affiliation Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯